Transcript Highlights:

• So it adds the words 'as a result of a mental disorder.'
• And then... ...as a result of a mental disorder.
• So it adds the words 'as a result of a mental disorder.'
• And if you jump back up to 23, it demonstrates that as a result of a mental disorder, the person lacks
• As a result of a mental disorder, the person lacks the decisional capacity. Thank you. Okay.

Bills: SB3 , HB70 , HB49 , HB60 , HB151 , HB164 , SB17 , SB35 , SB164

Committee: House House Judiciary

Summary: The committee first heard Senate Bill 3, which revises definitions in the Mental Health Code and Assisted Outpatient Treatment Act related to “likelihood of serious harm” and decisional capacity. The sponsor said the goal was to make the standards more workable for courts and treatment providers in civil commitment and assisted outpatient treatment cases. Members adopted a friendly amendment that narrowed and clarified the language, including adding “intentionally,” tying decisional capacity language to a mental disorder, and specifying that a qualified mental health professional makes that determination. A second friendly amendment was then adopted to make the bill’s language consistent throughout the code by adding “serious” before references to harm to self or others in several places. Public testimony on SB 3 was mixed. Disability advocates, the ACLU, and Disability Rights New Mexico expressed continued concern about involuntary treatment, civil liberty implications, possible overuse of commitment as a shortcut around guardianship or capacity procedures, and the risk that some people could remain in the system for a long time. Supporters included the Greater Albuquerque Chamber of Commerce, police, and firefighters, who said the bill would provide clearer standards, better tools for crisis response, and alternatives to repeated arrest or emergency hospital transport. After debate, the committee voted 10-0 to give SB 3 a due pass as twice amended. The committee then took up House Bill 70, which was presented with a committee substitute intended to make the bill “sleeker” and address concerns raised by members. The substitute restored existing limits on commission decision-making, strengthened hearing examiner independence, reinstated current ex parte and Open Meetings Act guardrails, removed a proposed consumer advocate provision, and changed one provision from “may” back to “shall.” Members asked a few clarifying questions, including about advocacy staff and hearing examiners, and the sponsor said the changes improved the bill. The committee voted 9-0 to do not pass the original bill and due pass the committee substitute. The chair announced the committee had completed its two bills and adjourned after discussing upcoming meeting times.

Transcript Highlights:

• I've been specializing in mental health and substance use disorders for over 20 years, and I've been
• And cannabis use disorder, you've already heard, is a big deal for young people.
• , psychosis and schizophrenia, mood and anxiety disorders, and suicidal behaviors.
• And cannabis use disorder, you've already heard, some of the time. the odds of cannabis use disorder.
• , my psychosis and schizophrenia, mood and anxiety disorders, and suicidal behaviors.

Committee: Joint Joint Committee on Cannabis Policy

Summary: The Joint Committee on Cannabis Policy held its fourth hearing, with opening remarks from Senate Chair Adam Gómez and House Chair Dan Donahue emphasizing the committee’s broad agenda, including retail modernization, labor protections, advertising rules, sustainability, and financial resources. Testimony began with public health advocates supporting H.157/S.9 to ban cannabis billboard advertising, arguing that billboards normalize use for youth and are linked to cannabis-related harms such as psychosis, addiction, and cannabinoid hyperemesis syndrome. Witnesses cited research, family stories, and court decisions in Mississippi and Virginia upholding similar restrictions, while committee members questioned the scope of the state’s authority to regulate billboards on private property and the relevance of federal highway funding and federal cannabis law. The committee also heard testimony on H.175, a proposal to allow cannabis drive-through sales. A dispensary operator argued drive-throughs would improve access, especially for disabled customers and veterans, and said security and ID checks could be handled with cameras and staff screening. Committee members pressed him on how employees would assess impairment, whether drive-throughs could increase access for minors, and whether the industry should be treated like alcohol, with the witness responding that staff already refuse service to intoxicated customers and that education, not prohibition, is the better approach. Another bill, H.3982, would apply the bottle deposit law to carbonated hemp- or THC-infused beverages; the sponsor said the measure would standardize recycling requirements for products already sold in dispensaries and other markets, and members asked about container types and recycling compatibility. A major portion of the hearing focused on labor peace agreements, with UFCW representatives, cannabis workers, and Sen. Lydia Edwards supporting S.77/H.161. They said the bill would require cannabis businesses to remain neutral when workers seek to organize, arguing that unions improve safety, wages, benefits, and job stability in an industry they described as underregulated and prone to retaliation. Witnesses cited workplace hazards, wage theft, and the death of a worker at a Holyoke facility as examples of why stronger worker protections are needed. Committee members asked how the proposal differs from existing labor law, whether tying LPAs to licensing and renewal could create legal or administrative problems, and how other states handle similar requirements. No votes or final actions were taken during the hearing.

Transcript Highlights:

• </c> patients with major depressive disorder patients with major depressive disorder don't<01:32:50.239
• </c> While the data and opioid use disorder While the data and opioid use disorder is<01:35:45.040><c
• :40:58.800><c> to</c> substance use disorders continue to substance use disorders continue to consume
• ,</c><01:42:34.560><c> retired</c> with alcohol use disorder, retired with alcohol use disorder, retired
• So, um, other examples of disorders.

Committee: Senate Health and Human Services

Transcript Highlights:

• /c><00:12:12.640><c> use</c> services, including substance use services, including substance use disorder
• treatment and incarceration for disorder treatment and incarceration for drug<00:12:15.280><c> offenses
• around behaviors, and reducing stigma around mental<00:13:05.720><c> health</c><00:13:05.960><c> disorders
• </c><00:13:06.839><c> Number</c><00:13:07.120><c> two,</c> mental health disorders.
• Number two, mental health disorders.

Bills: HCR67 , HCR102 , HR61 , HR94

Committee: House Human Services & Homelessness

Summary: The joint Committee on Human Services and Homelessness and Committee on Health heard two measures on April 7, 2026. HCR 67/HR 61 would request the Disability and Communication Access Board to study communication needs in health care settings for people who are deaf, hard of hearing, or deaf-blind and develop guidelines. Written testimony supported the measure from the State Health Planning and Development Agency, DCAB, Local Independent Living Hawaii, and one individual. A DCAB representative noted the proposal could serve as a backup if related measures do not move forward. No one testified in opposition, and both committees voted to pass the measure unamended. The second measure, HCR 102/HR 94, urged the Department of Education, in collaboration with the Department of Health and the Office of Wellness and Resilience, to establish a statewide peer counselor program to address youth loneliness and social disconnection in schools. Support came from the Department of Education, the Office of Wellness and Resilience, and individual testifiers Katie Smith and Ray Ward. Smith said peer support can reduce stigma, increase belonging, and improve school climate. Ward, speaking from lived experience, described the harms of loneliness and trauma and said a peer counselor program could provide culturally grounded support and safer pathways to help. No opposition was offered, and both committees voted to pass the measure unamended.

Transcript Highlights:

• He lives with schizoaffective disorder, grandiose personality disorder, and was born with autistic markers
• Mental health and substance use disorders are chronic, relapsing conditions, but recovery and sustained
• With regard to a person experiencing their first symptoms related to the onset of a psychotic disorder
• But there is another presentation about updates to the substance use disorder treatment standards and
• In fact, For substance use disorder treatment, so that we can, in fact, align our state standards for

Transcript Highlights:

• He lives with schizoaffective disorder, grandiose personality disorder, and was born with autistic markers
• Mental health and substance use disorders are chronic, relapsing conditions, but recovery and sustained
• But there is another presentation about updates to the substance use disorder treatment standards and
• I don't have any other questions on the substance use disorder treatment standards, but thank you for
• Just in terms of the Substance Use Disorder Pilot Program, I would like to know more information about

Summary: The hearing focused first on behavioral health, especially serious mental illness and anosognosia, a condition described by witnesses as a neurological symptom that prevents people from recognizing they are ill. The chair framed the issue around families cycling through emergency rooms, jails, conservatorships, and short-term stabilization without lasting treatment, and warned that federal changes under H.R. 1 could reduce Medi-Cal funding and worsen access. Dawn Marie Anderson gave a personal account of her son’s long history of psychosis, homelessness, arrests, repeated jail and state hospital stays, and eventual stability when he received sustained medication and coordinated support. She argued that the system often treats the problem as criminal rather than medical and that voluntary programs and short-term services are not enough for people who lack insight into their illness. Other panelists, including representatives from the California Behavioral Health Association, Santa Barbara County Behavioral Health, and the County Behavioral Health Directors Association, agreed that anosognosia is not denial or noncompliance and said the system needs long-term, coordinated care, including assertive community treatment, mobile crisis, supportive housing, medication support, and stronger handoffs between county and managed care systems. They said CalAIM and other reforms have improved some coordination, but significant gaps remain, especially for people with serious mental illness, for those in jail or locked settings, and for people with private insurance, which witnesses said often offers little meaningful coverage for early psychosis or intensive behavioral health services. Several witnesses urged the Legislature to protect Medi-Cal, shore up county safety-net services, and invest in training and family engagement. The committee then turned to the Children and Youth Behavioral Health Initiative, with a focus on the virtual services platforms BrightLife Kids and Soluna and the CYBHI fee schedule. DHCS reported strong growth in app registrations, coaching sessions, referrals, and positive user outcomes, saying the platforms provide free, culturally responsive, early-intervention support statewide and help connect users to higher levels of care when needed. On the fee schedule, DHCS said more than 500 LEAs, colleges, universities, and school-linked providers are participating, 181 LEAs have submitted claims, and $9.6 million has been reimbursed to date, with 41,556 students represented in claims. The chair and several members criticized the pace of implementation and the amount of money spent relative to reimbursement levels, saying the Legislature had requested data earlier and that the return on investment still appeared low. DHCS responded that many claims are still being submitted, that 70% of denials are correctable, that $400 million in capacity grants has been distributed locally, and that reimbursement is increasing rapidly as more districts come online. Public comment included a rural county behavioral health director who said private insurance denials leave counties with significant uncompensated work, especially for unlicensed staff providing case management and mobile crisis services.

Transcript Highlights:

• I think the other thing that we have are some services that we are using to treat substance use disorders
• So with youth and adolescent, we're also opening up a substance use disorder unit.
• This is our first residential substance use disorder treatment.
• Do they have access to services and people that are trained to provide substance use disorder services
• So there is a disallowance that says Medicaid cannot pay for a substance use disorder service if those

Committee: All PUBLIC HEALTH- HOUSE HEALTH SERVICES SUBCOMMITTEE

Summary: The House Health Services Subcommittee met to approve the October 7, 2024 minutes and then shifted to a broad discussion of behavioral health policy, taking up work previously handled by a behavioral health working group. Representatives Wooldridge and Vaught described major gaps in Arkansas behavioral health care, emphasizing access problems, workforce shortages, rural service barriers, low reimbursement, and the need to move from a reactive crisis system to more proactive community-based care. Members discussed possible 2027-session priorities such as reducing red tape, improving provider licensing and supervision pathways, expanding billing codes and reimbursement structures, and considering interstate compacts and other workforce fixes. A major focus was the state’s crisis and forensic system, including long waits for competency evaluations, the backlog at the Arkansas State Hospital, and the use of county jails for people awaiting treatment. DHS Director Paula Stone explained that Medicaid pays for most behavioral health services, but cannot pay for services in jails or state hospitals because those individuals are treated as inmates of public institutions, leaving state general revenue to cover much of that cost. She outlined DHS efforts including secured restoration beds, therapeutic communities, community mental health center contracts for jail-based services, and plans for an institution-for-mental-disease waiver that could allow Medicaid payment for certain hospital-based services. Members also discussed crisis stabilization units, with DHS noting that Fort Smith and Jonesboro have been more successful than Fayetteville and Little Rock, largely because of location, partnerships, and law enforcement coordination. Questions covered reimbursement for county jails, step-down facilities, civil commitment options, non-emergency behavioral health transportation, and whether DHS should create a bed-availability dashboard similar to hospital systems. DHS said it does not currently have such a dashboard but is exploring the idea. The meeting ended with a commitment to continue the work, with more detailed discussion planned for August, and the subcommittee adjourned.

Transcript Highlights:

• and the mortal stronghold it disorder and the mortal stronghold it has<00:58:44.160><c> on</c><00:58
• </c> to substance use disorder. Mr. to substance use disorder. Mr.
• President, more people are affected by substance use disorder than any one of these other conditions
• Inpatient substance use disorder clinics see a 68% program completion rate.
• Senator from Shelby. to get rid of substance use disorder. to get rid of substance use disorder.

Transcript Highlights:

• , post-traumatic stress disorder.
• and police officers and other folks who have worn the uniform about their post-traumatic stress disorder
• Looking at anxiety disorder, and others. So very exciting news. So recently, Mr.
• But let's say that this did become a mainstream drug for the treatment of psychiatric disorders.
• , with or without psychosis, generalized anxiety disorder, and PTSD.

Summary: The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies met to discuss psychedelic-assisted treatments for serious mental health conditions, with a focus on psilocybin, ibogaine, MDMA, and related compounds. The chair framed the issue as a clinical and access problem for veterans, first responders, and others with PTSD, depression, TBI, addiction, and suicidal ideation, emphasizing that these therapies are intended for supervised medical settings rather than take-home use. Members reviewed research claims and policy trends, including FDA breakthrough therapy designations, state-level psychedelic legislation, and the role of Arizona’s right-to-try law in expanding access once federal approval is in place. Testimony came from Alan Mullen, a retired Army Special Forces veteran, who described his PTSD/TBI history and said ibogaine treatment helped him confront trauma and showed promise in reducing symptoms under strict medical monitoring. Dr. Sue Cisley of Scottsdale Research Institute described ongoing FDA-controlled trials in Arizona, said current medications often fail high-need patients, and urged removal of research barriers and preparation for right-to-try and expanded access. Dan Freiberg of the Professional Firefighters of Arizona said firefighters face chronic exposure to trauma, often rely on alcohol or other coping mechanisms, and need effective alternatives beyond traditional therapy. Dr. Chung Trin discussed late-stage psychedelic trials, the FDA breakthrough pathway, safety oversight, and the need for state readiness when approvals occur. Committee members asked about how the treatments work, whether they require psychotherapy support, safety concerns including suicidality and black-market abuse, patenting and synthetic versus natural versions, and costs compared with ketamine and other treatments. Witnesses said the therapies are administered with extensive screening, monitoring, and integration support, and argued that addiction potential appears low under medical supervision. The discussion ended with interest in sending correspondence to federal officials to support right-to-try cooperation and in continuing the research and policy work; no formal vote or action was taken in the portion provided.

Transcript Highlights:

• , post-traumatic stress disorder.
• and police officers and other folks who have worn the uniform about their post-traumatic stress disorder
• Looking at anxiety disorder, and others. So very exciting news. Recently, Mr.
• But let's say that this did become a mainstream drug for the treatment of psychiatric disorders.
• , with or without psychosis, generalized anxiety disorder, and PTSD.

Summary: The Senate Ad Hoc Committee on Access to Breakthrough Mental Health Therapies held an informational hearing focused on psychedelic-assisted treatments for PTSD, depression, addiction, and related conditions, especially for veterans, first responders, and firefighters. The chair framed the issue as a response to long-standing barriers created by Schedule I restrictions and stigma, emphasizing that the committee was looking at supervised clinical use rather than take-home drugs. Members discussed the growing number of state psychedelic policy proposals, the federal breakthrough therapy pathway, and the idea of Arizona preparing for FDA approval and possibly sending correspondence to federal officials in support of expanded access and Right to Try implementation. Witnesses included retired Army Special Forces Master Sgt. Alan Mullen, who described participating in an ibogaine study for PTSD/TBI and said the treatment, combined with preparation and integration support, helped him confront trauma and showed promise under strict medical monitoring. Dr. Sue Sisley of Scottsdale Research Institute testified that her team is conducting FDA-controlled psychedelic trials, including psilocybin research funded by Arizona, and argued that these therapies can produce major symptom relief with limited doses when delivered in controlled settings. She also urged the legislature to help remove barriers to research and access, including support for Right to Try and possible federal action to allow controlled-substance access. Dan Freiberg of the Professional Fire Fighters of Arizona said firefighters face chronic mental health exposure and often lack effective options beyond traditional therapy or, in some cases, ketamine, and he supported any safe, effective treatment that could help members return to work and reduce suicide risk. Dr. Chung Trin, a mental health physician and trial investigator, explained the FDA breakthrough designation process, said several psychedelic treatments are in late-stage review, and stressed the need for Arizona to build clinical infrastructure so patients can access approved therapies quickly and safely once federal approval occurs. Committee members asked about safety, addiction potential, suicide risk, costs, patents, and whether natural versus synthetic versions of compounds like psilocybin would be available; the hearing ended with general support for continued research, possible legislative correspondence to federal officials, and no formal vote or bill action taken.

Transcript Highlights:

• I'm also in support of Bill H-2413 about adding the electromagnetic sensitivity disorder to the MAVEN
• Next, moving on to S-1635, an act authorizing pharmacists to provide opioid use disorder treatment.
• So when we talk about opioid use disorder treatment, I want to focus on buprenorphine, or the safest
• and most effective opioid treatment for opioid use disorder, which decreases deaths from opioid use disorder
• But for buprenorphine, for opioid use disorder treatment, three out of four people who want treatment

Committee: Joint Joint Committee on Public Health

Summary: The Joint Committee on Public Health held a hearing focused on children’s health, disease prevention, screening, treatment, and pharmacy-related bills. The chair explained that the session was for public testimony only, with no votes or decisions taken that day, and outlined the three-minute limit for individual testimony. The committee then heard testimony on a range of bills, including H. 2413 on adding electromagnetic sensitivity to the state’s MAVEN registry, S. 1508 and H. 2433 on creating an amputation prevention task force, H. 2535 and S. 1551 on establishing a naloxone purchase trust fund, S. 1635 on authorizing pharmacists to provide opioid use disorder treatment, H. 2385 on creating a special commission on avian influenza, and S. 1497 on patient safety and non-FDA-approved compounded drugs. Testimony on H. 2413 came largely from advocates and individuals who described electromagnetic sensitivity as a real health condition and argued that adding it to the registry would improve data collection, provider education, and public awareness. Testimony on the amputation prevention task force bills came from the American Diabetes Association and podiatry groups, who said diabetes-related amputations are often preventable, disproportionately affect people of color, and could be reduced through earlier screening, better care coordination, and improved insurance coverage for preventive foot care. On the naloxone trust fund bills, a representative, emergency physician, and nurse testified that hospitals often cannot reliably send overdose patients home with naloxone because of billing and reimbursement barriers, and that a bulk-purchase fund would expand access at no added cost to payers or providers. The committee also heard strong support for S. 1635 from pharmacists and public health researchers, who said community pharmacists could safely initiate and maintain buprenorphine treatment and help close gaps in opioid use disorder care. On H. 2385, a local board of health chair supported a special commission on avian influenza, citing gaps in emergency preparedness and the need for clearer coordination across agencies. On S. 1497, a pharmacy representative opposed restrictions on compounded drugs from outsourcing facilities, warning that changes could reduce access to life-saving medications and harm patient safety. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• Okay, so there is that option for medication for opioid disorder? Okay.
• Substance use disorder is an illness.
• Our patients often struggle with serious mental illness, substance use disorder, personality disorders
• I am the mother of a 34-year-old son who lives with a severe schizoaffective disorder.
• My son has schizoaffective disorder.

Committee: Joint Joint Committee on Mental Health, Substance Use and Recovery

Summary: The committee held its fourth public hearing of the 2025-2026 session on bills dealing with involuntary commitment and access to addiction treatment, especially proposals to move Section 35 civil commitments away from jails and prisons and into facilities licensed or approved by DPH or DMH. Chairs Velis and Domb framed the hearing as a discussion of how to support people in crisis with compassion, while also warning against using involuntary commitment as a way to remove unhoused people from public view. The hearing also touched on related concerns about discharge practices, treatment capacity, and the need for a broader continuum of care. Testimony split largely along two themes. Addiction researcher Keith Humphreys argued that many people enter treatment under pressure, that involuntary treatment can be ethically justified in the face of overdose risk, but that it should not be mandated unless high-quality services exist first; he emphasized the need for inpatient care when someone is a grave danger, followed by case management and outpatient support. MAMH’s Kate Alicante supported the bill, saying Massachusetts is the only state that commits people with substance use conditions to jails or prisons and that carceral settings add trauma and stigma; she pointed to prior legislative steps, including the Section 35 commission and the planned closure of DOC’s MESAC facility, as evidence that the Commonwealth is moving toward health-based settings. A major portion of the hearing focused on Stony Brook, a sheriff-run stabilization and treatment center in Hampden County. Boston City Councilor John Fitzgerald, several committee members, and multiple people in recovery described the facility as humane, well-run, and effective, with longer stays, medical monitoring, medication-assisted treatment, counseling, and warm handoffs to aftercare. Several witnesses said Stony Brook saved their lives or helped family members recover, and they argued that the sheriff’s office model should be expanded rather than eliminated. Others, including family members and advocates, countered that even a well-run correctional setting remains stigmatizing and that people should not be treated in facilities run by sheriffs or corrections when they have committed no crime. No vote was taken. The hearing concluded with continued testimony, including Senator Friedman’s support for Section 35 as a civil commitment tool but not in a criminal justice setting, and her separate support for a bill to speed inpatient mental health treatment.

Transcript Highlights:

• It updates definitions to reflect current medical understanding, including neurocognitive disorders like
• date, gives us an option to use the same procedure for folks with a neurocognitive disability or disorder
• Would you explain more the neurocognitive disorders and how that plays in, maybe describe what that is
• Yes, so neurocognitive disorders, I think traditionally what we look at and what we think of are like
• This also creates a pathway with neurocognitive disorders where, when the people who are suffering from

Committee: House Judiciary, Rules and Administration

Transcript Highlights:

• also funded a $2 million... ...clinical trial for veterans and first responders with co-occurring disorders
• of alcohol use disorder and PTSD.
• I currently specialize in eating disorders, specifically anorexia nervosa.
• DMT, LSD, and methalone for treatment-resistant depression, anxiety, PTSD, and adjustment disorder and
• , you know, we've had 200 years of intensive research. ...based on the DSM disorders, you know, we've

Bills: SB5921 , SB5185 , SB6182 , SB6115 , SB6258 , SB5916 , SB5981 , SB5985 , SB6019 , SB6161 , SB6183

Committee: Senate Health & Long-Term Care

Keywords: psilocybin, mental health, therapy, decriminalization, legalization, international medical graduates, preceptorship, hardship pathways, medical practice, licensure, abortion, reproductive health, pregnancy termination, clinic access, abortion access fund, abortion savings account, health carrier assessment, insurance assessment, health insurer tax, Department of Health

Transcript Highlights:

• It updates and adds post-traumatic stress disorder to serious and persistent mental illness for purposes
• Also from House File 2143, Sections 5, 7 through 10, and 35 add complex post-traumatic stress disorder
• The professionals who may conduct a substance use disorder comprehensive assessment.
• Section 14 from the DHS policy bill clarifies comprehensive substance use disorder treatment assessment
• Section 16 from the DHS policy bill modifies substance use disorder treatment guest speaker documentation

Bills: HF2115 , HF2276 , HF1644 , HF99 , HF2068 , HF2707 , HF2704 , HF2406 , HF1674 , HF1579

Committee: House Human Services Finance and Policy

Transcript Highlights:

• One in three people who have given birth will suffer from postpartum pelvic floor health disorders in
• Mental health and substance use disorders affect millions of Californians and are a growing health challenge
• federal rules into state law to preserve Californians' existing mental health and substance use disorder
• effectively determine whether insurers are restricting access to mental health and substance use disorder
• our shared goal of ensuring timely access to medically necessary mental health and substance use disorder

Summary: The Senate Committee on Health heard presentations on several bills, beginning with AB 1734, which would expand California Health Interview Survey food insecurity data collection to households up to 400% of the federal poverty level. The author and supporters from food banks, AARP, county governments, and nutrition groups argued the bill would improve California’s ability to measure hunger amid federal cuts; there was no opposition. The committee also heard AB 1949, which would treat acupuncture as its own Medi-Cal benefit and allow up to 24 visits per year. Supporters said the current two-visits-per-month cap limits effective treatment and can increase reliance on medications; the bill drew broad support and no opposition. AB 1910, a postpartum pelvic floor health bill, was presented as an education and awareness measure encouraging patients to discuss pelvic floor concerns with providers, with no opposition. AB 2011 would codify federal mental health parity standards into state law; supporters said it would preserve enforcement if federal rules are rolled back, while insurers opposed it as premature given ongoing federal litigation and possible new rules. AB 2706 would modernize California’s cannery law to align with federal food safety standards and reduce duplicative requirements for food processors, with support from the dairy industry and no opposition. AB 2041 would require certain public safety agencies to report compliance with 911 dispatcher pre-arrival instruction training requirements, building on prior legislation; it also faced no opposition. After quorum was established, the committee voted on the bills. The consent calendar bills AB 1571, AB 1864, and AB 1956 were approved 6-0. AB 1734, AB 1910, AB 1949, AB 2041, and AB 2706 all passed the committee unanimously or near-unanimously and were re-referred to Appropriations or Education as applicable. AB 2011 passed 8-2, with some members expressing concern about federal litigation, implementation costs, and the timing of codifying the 2024 parity rule into state law. All bills were placed on call after the votes, and the committee adjourned after completing its agenda.

Transcript Highlights:

• We have missed the genetic revolution with the New World screwworm.
• But that work is going to take decades for the genetics... ...the genetically engineered organisms to
• The cattle that we've been importing is really U.S. cattle because we've sent our genetics over there

Committee: Senate Water, Agriculture and Rural Affairs

Transcript Highlights:

• It hasn't been genetically modified.
• It hasn't been genetically<00:52:23.040><c> modified.
• </c><00:52:24.280><c> Uh</c> genetically modified. Uh genetically modified.

Bills: HF3426 , HF3896 , HF1426 , HF3793 , HF4061 , HF4246

Committee: House Environment and Natural Resources Finance and Policy

Transcript Highlights:

• He has a rare genetic brain disease. It's a terminal diagnosis.
• He</c><00:40:17.839><c> has</c><00:40:17.920><c> a</c><00:40:18.079><c> rare</c><00:40:18.320><c> genetic
• He has a rare genetic brain child.
• He has a rare genetic brain disease.<00:40:19.680><c> It's</c><00:40:19.920><c> terminal</c><00:40:20.320

Bills: SF0099 , SF0116 , SJ0006

Committee: Senate Judiciary

Transcript Highlights:

• I'll never forget the kid I had that had gray in his hair, a big shard of it, and I thought it was genetic
• a big Shard of it and I thought<01:31:16.119><c> it</c><01:31:16.239><c> was</c><01:31:16.480><c> genetic
• /c><01:31:17.000><c> I</c><01:31:17.159><c> never</c><01:31:17.360><c> thought</c> thought it was genetic
• I never thought thought it was genetic I never thought anything<01:31:17.800><c> of</c><01:31:17.960

Committee: Senate Education Policy